Detalles de la búsqueda
1.
Weekly Icodec versus Daily Glargine U100 in Type 2 Diabetes without Previous Insulin.
N Engl J Med
; 389(4): 297-308, 2023 Jul 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-37356066
2.
Calcifediol: a review of its pharmacological characteristics and clinical use in correcting vitamin D deficiency.
Eur J Nutr
; 62(4): 1579-1597, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-36862209
3.
Once-weekly tirzepatide versus once-daily insulin degludec as add-on to metformin with or without SGLT2 inhibitors in patients with type 2 diabetes (SURPASS-3): a randomised, open-label, parallel-group, phase 3 trial.
Lancet
; 398(10300): 583-598, 2021 08 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-34370970
4.
Glycaemic variability in patients with type 2 diabetes mellitus treated with dulaglutide, with and without concomitant insulin: Post hoc analyses of randomized clinical trials.
Diabetes Obes Metab
; 24(4): 631-640, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34866291
5.
Semaglutide improves health-related quality of life versus placebo when added to standard of care in patients with type 2 diabetes at high cardiovascular risk (SUSTAIN 6).
Diabetes Obes Metab
; 22(8): 1339-1347, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32227613
6.
Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
N Engl J Med
; 375(19): 1834-1844, 2016 11 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-27633186
7.
Cardiovascular risk reduction with once-weekly semaglutide in subjects with type 2 diabetes: a post hoc analysis of gender, age, and baseline CV risk profile in the SUSTAIN 6 trial.
Cardiovasc Diabetol
; 18(1): 73, 2019 06 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31167654
8.
Fixed-ratio combination of insulin degludec and liraglutide (IDegLira) improves cardiovascular risk markers in patients with type 2 diabetes uncontrolled on basal insulin.
Diabetes Obes Metab
; 21(6): 1506-1512, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30785655
9.
IDegLira improves patient-reported outcomes while using a simple regimen with fewer injections and dose adjustments compared with basal-bolus therapy.
Diabetes Obes Metab
; 21(12): 2643-2650, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31385425
10.
Insulin degludec/liraglutide (IDegLira) was effective across a range of dysglycaemia and body mass index categories in the DUAL V randomized trial.
Diabetes Obes Metab
; 20(1): 200-205, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28643425
11.
Placebo-controlled, randomized trial of the addition of once-weekly glucagon-like peptide-1 receptor agonist dulaglutide to titrated daily insulin glargine in patients with type 2 diabetes (AWARD-9).
Diabetes Obes Metab
; 19(7): 1024-1031, 2017 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-28294499
12.
High prevalence of undiagnosed vertebral fractures in patients suffering from hip fracture at their hospital admission: weak concordance among observers.
Aging Clin Exp Res
; 27(6): 835-9, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-25911609
13.
Efficacy and Safety of Calcifediol in Young Adults with Vitamin D Deficiency: A Phase I, Multicentre, Clinical Trial-POSCAL Study.
Nutrients
; 16(2)2024 Jan 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-38276544
14.
Osteoporosis and metabolic syndrome according to socio-economic status, contribution of PTH, vitamin D and body weight: The Canarian Osteoporosis Poverty Study (COPS).
Clin Endocrinol (Oxf)
; 78(5): 681-6, 2013 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-23009563
15.
Two-year effect of semaglutide 2.4 mg on control of eating in adults with overweight/obesity: STEP 5.
Obesity (Silver Spring)
; 31(3): 703-715, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36655300
16.
Long-Term Treatment and Effect of Discontinuation of Calcifediol in Postmenopausal Women with Vitamin D Deficiency: A Randomized Trial.
J Bone Miner Res
; 38(4): 471-479, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36661855
17.
Bone loss after heart transplant: effect of alendronate, etidronate, calcitonin, and calcium plus vitamin D3.
Prog Transplant
; 22(3): 237-43, 2012 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-22951500
18.
Benefits of SGLT2i for the Treatment of Heart Failure Irrespective of Diabetes Diagnosis: A State-of-the-Art Review.
Diabetes Ther
; 13(Suppl 1): 19-34, 2022 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-35704165
19.
Effective Overall Glycaemic Control with Fast-Acting Insulin Aspart Across Patients with Different Baseline Characteristics: A Post Hoc Analysis of the Onset 9 Trial.
Diabetes Ther
; 13(4): 761-774, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-35290624
20.
Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial.
Nat Med
; 28(10): 2083-2091, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-36216945